TQB3117

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3117, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer [Phase 1]